← 홈

CGT · 고형암 (전체)

149개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 149개
CGTBiologicstaleThe Sixth Affiliated Hospital o…Phase 1

CAR-T therapy for nectin4-positive malignant solid tumor (CAR-T therapy for nectin4-positive malignant solid tumor)

Nectin4-positive Advanced Malignant Solid Tumor · Nectin4-positive Advanced Malignant Soli

#Nectin4-positiveAdvancedMalignan#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleSorrento Therapeutics, Inc.Phase 1

CAR2 Anti-CEA CAR-T cells (CAR2 Anti-CEA CAR-T cells)

Metastatic Pancreatic Carcinoma · CEA

#CEA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleChinese PLA General HospitalPhase 2

CART-EGFR (CART-EGFR)

Advanced EGFR-positive Solid Tumors · EGFR

#EGFR#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

CART-HER-2 (CART-HER-2)

Advanced HER-2 Positive Solid Tumors; Chemotherapy Refactory · Advanced HER-2 Positive Solid Tumors

#AdvancedHER-2PositiveSolidTumors#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

CART-meso (CART-meso)

Metastatic Pancreatic (Ductal) Adenocarcinoma; Epithelial Ovarian Cancer · Metastatic Pancreatic (Ductal) Adenocarc

#MetastaticPancreaticDuctalAdenoc#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleZhejiang Provincial People's Ho…Phase 1

CB CAR-NK18.2 (CB CAR-NK18.2)

Gastric Cancer; Pancreas Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleXijing HospitalPhase 1

CD147-CART (CD147-CART)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShenzhen University General Hos…Phase 2

CD276 CAR-T cells (CD276 CAR-T cells)

Advanced Pancreatic Carcinoma · Advanced Pancreatic Carcinoma

#AdvancedPancreaticCarcinoma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity Hospital TuebingenPhase 2

CD318-CAR-T cells (CD318-CAR-T cells)

Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms · CD3

#CD3#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

CD73/AXL.HypoSti.CAR-T cells (CD73/AXL.HypoSti.CAR-T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA CAR-T cells (CEA CAR-T cells)

Solid Tumor; Lung Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleShenzhen University General Hos…Preclinical

Claudin18.2 CAR-T cells (Claudin18.2 CAR-T cells)

Advanced Pancreatic Carcinoma; Advanced Gastric Carcinoma · Advanced Pancreatic Carcinoma

#AdvancedPancreaticCarcinoma#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

Dual-target CAR-NK cell product (Dual-target CAR-NK cell product)

Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting CLDN18.2 and PD-L1 CAR-T cells (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

Advanced Solid Tumor · PD-L1

#PD-L1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting HER2 and PD-L1 CAR-T cells (Dual-targeting HER2 and PD-L1 CAR-T cells)

Peritoneal Carcinoma Metastatic; Pleural Effusion, Malignant · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EB-CAR30-NK (EB-CAR30-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EB-CAR5-NK (EB-CAR5-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EB-CARMSLN-NK (EB-CARMSLN-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

MSLN + MUC1 (EB-DNK101 dual-targeting CAR-NK cells, EB-DNK101 dual-targeting CAR-NK cells (MSLN + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · Pancreatic Ductal Adenocarcinoma (PDAC)

#PancreaticDuctalAdenocarcinomaPD#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

CLDN18.2 + MUC1 (EB-DNK102 dual-targeting CAR-NK cells, EB-DNK102 dual-targeting CAR-NK cells (CLDN18.2 + MUC1))

Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Disease · CLDN18.2

#CLDN182#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

4 / 8 페이지

← 이전다음 →